Alnylam Pharmaceuticals Inc (ALNY)
280.96
-9.74
(-3.35%)
USD |
NASDAQ |
Mar 25, 16:00
280.77
-0.19
(-0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly): 4.240B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 213.40B |
| Biomarin Pharmaceutical Inc | 6.989B |
| BridgeBio Pharma Inc | 919.34M |
| Regeneron Pharmaceuticals Inc | 37.76B |
| Vertex Pharmaceuticals Inc | 22.53B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.173B |
| Shareholders Equity (Quarterly) | 67.09M |
| Debt to Equity Ratio | 15.27 |
| Current Ratio | 2.778 |
| Net Debt Paydown Yield | -0.00% |